| |
| |
|
| Insider
Information: |
Rolland Alain P Phd |
| Relationship: |
Exec VP, Product Devel... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
127,583 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$86,246 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
127,583 |
|
|
| Total
Value |
$86,246 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fresh Tracks Therapeutics Ord Shs |
FRTX |
Exec VP, Product Devel... |
2013-08-22 |
127,583 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FRTX |
Fresh Tracks Therapeutics... |
Exec VP, Product Development |
• – – |
2013-08-22 |
4 |
D |
$1.33 |
$17,991 |
D/D |
(13,527) |
127,583 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Exec VP, Product Development |
• – – |
2013-07-13 |
4 |
D |
$3.73 |
$2,208 |
D/D |
(592) |
172,542 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Exec VP, Product Development |
• – – |
2013-07-11 |
4 |
D |
$3.72 |
$4,081 |
D/D |
(1,097) |
173,134 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Exec VP, Product Development |
• – – |
2013-07-07 |
4 |
D |
$3.61 |
$4,754 |
D/D |
(1,317) |
174,231 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Exec VP, Product Development |
• – – |
2013-04-13 |
4 |
D |
$4.13 |
$2,449 |
D/D |
(593) |
175,548 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Exec VP, Product Development |
• – – |
2013-04-11 |
4 |
D |
$4.10 |
$4,502 |
D/D |
(1,098) |
176,141 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Exec VP, Product Development |
• – – |
2013-04-07 |
4 |
D |
$4.21 |
$5,545 |
D/D |
(1,317) |
177,239 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Exec VP, Product Development |
• – – |
2013-01-13 |
4 |
D |
$3.31 |
$7,845 |
D/D |
(2,370) |
178,556 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Exec VP, Product Development |
• – – |
2013-01-11 |
4 |
D |
$3.31 |
$3,631 |
D/D |
(1,097) |
180,926 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Exec VP, Product Development |
• – – |
2013-01-11 |
4 |
B |
$0.01 |
$221 |
D/D |
22,092 |
182,023 |
2.66 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Exec VP, Product Development |
• – – |
2013-01-09 |
4 |
D |
$3.28 |
$2,519 |
D/D |
(768) |
159,931 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Exec VP, Product Development |
• – – |
2013-01-07 |
4 |
D |
$3.11 |
$4,093 |
D/D |
(1,316) |
160,699 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Exec VP, Product Development |
• – – |
2012-10-11 |
4 |
D |
$4.05 |
$4,447 |
D/D |
(1,098) |
162,015 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Exec VP, Product Development |
• – – |
2012-10-09 |
4 |
D |
$4.03 |
$3,095 |
D/D |
(768) |
163,113 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Exec VP, Product Development |
• – – |
2012-10-07 |
4 |
D |
$4.32 |
$5,694 |
D/D |
(1,318) |
163,881 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Exec VP, Product Development |
• – – |
2012-07-11 |
4 |
D |
$3.55 |
$3,894 |
D/D |
(1,097) |
165,199 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Exec VP, Product Development |
• – – |
2012-07-09 |
4 |
D |
$3.58 |
$2,749 |
D/D |
(768) |
166,296 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Exec VP, Product Development |
• – – |
2012-07-07 |
4 |
D |
$3.59 |
$4,728 |
D/D |
(1,317) |
167,064 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Exec VP, Product Development |
• – – |
2012-04-11 |
4 |
D |
$3.14 |
$3,445 |
D/D |
(1,097) |
168,381 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Exec VP, Product Development |
• – – |
2012-04-09 |
4 |
D |
$3.18 |
$2,442 |
D/D |
(768) |
169,478 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Exec VP, Product Development |
• – – |
2012-04-07 |
4 |
D |
$3.34 |
$4,399 |
D/D |
(1,317) |
170,246 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Exec VP, Product Development |
• – – |
2012-01-13 |
4 |
B |
$0.01 |
$270 |
D/D |
27,000 |
171,563 |
2.66 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Exec VP, Product Development |
• – – |
2012-01-11 |
4 |
D |
$3.76 |
$4,128 |
D/D |
(1,098) |
144,563 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Exec VP, Product Development |
• – – |
2012-01-04 |
4 |
D |
$4.28 |
$467 |
D/D |
(109) |
151,698 |
0 |
- |
|
| FRTX |
Fresh Tracks Therapeutics... |
Exec VP, Product Development |
• – – |
2011-10-11 |
4 |
D |
$2.75 |
$3,014 |
D/D |
(1,096) |
151,807 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
